Regenxbio Inc
Statements
Cash Flow
Regenxbio Inc (RGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -20 | -17 | -9.5 | -17 | -14 | 58 | 70 | -20 | -4.1 | -29 | -24 | -29 | -26 | -36 | -21 | -36 | 39 | -44 | -30 | -43 | 326 | -56 | -62 | -50 | -39 | -81 | -47 | -49 | -41 | -55 | -45 | -41 | -32 | 34 | -49 | -56 | -52 | -76 | -62 | -247 | |
| 0.2 | 0.3 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 0.9 | 1.3 | 1.6 | 1.7 | 1.9 | 1.9 | 2.0 | 2.1 | 2.2 | 2.1 | 1.9 | 2.2 | 2.8 | 2.6 | 2.6 | 2.6 | 3.5 | 4.1 | 4.2 | 4.4 | 4.4 | 4.3 | 4.2 | 4.1 | 4.0 | 4.0 | 4.0 | 3.9 | 3.9 | 3.9 | 3.9 | 3.8 | 15 | |
| 1.8 | 2.0 | 2.6 | 2.5 | 2.7 | 2.8 | 3.3 | 4.0 | 4.5 | 4.9 | 5.7 | 7.1 | 7.2 | 6.9 | 8.0 | 8.3 | 8.0 | 7.6 | 9.9 | 10.0 | 9.7 | 9.2 | 11 | 10 | 10 | 9.4 | 11 | 11 | 10 | 8.3 | 9.6 | 9.4 | 9.9 | 9.5 | 8.5 | 8.7 | 9.0 | 8.4 | 8.6 | 9.1 | 35 | |
| 1.8 | 8.6 | 2.2 | 2.5 | 2.7 | 12 | 3.3 | 4.0 | 4.5 | 4.9 | 6.0 | 7.2 | 7.1 | 0.8 | 1.0 | 8.7 | 23 | 8.3 | 17 | 18 | 16 | -12 | 11 | 12 | 10 | 9.6 | 11 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 3.9 | -3.2 | 1.3 | 1.3 | 0.1 | -1.8 | -49 | 61 | -5.9 | -14 | -3.7 | 1.6 | -4.7 | 1.6 | -9.9 | 6.8 | -71 | 88 | -11 | 7.9 | 1.4 | 42 | 6.0 | -8.9 | 10.0 | 6.8 | -30 | 10 | -0.6 | 9.2 | -8.2 | -4.0 | 6.1 | 12 | 16 | 7.5 | -10 | -1.8 | -1.5 | -103 | -117 | |
| 2.2 | 4.4 | 2.9 | 1.7 | 0.5 | 2.1 | 2.3 | 2.7 | 3.4 | 4.9 | 2.5 | 5.6 | 2.7 | 1.0 | 4.6 | 3.3 | 6.1 | 13 | 31 | 20 | 19 | 15 | 11 | 9.2 | 5.1 | 5.5 | 4.8 | 2.6 | 1.4 | 1.1 | 0.6 | 0.5 | 0.3 | 1.1 | 1.0 | 0.4 | 0.5 | 0.5 | 1.2 | 0.8 | 3.0 | |
| 9.8 | 17 | 3.2 | -26 | 19 | -1.1 | -37 | -38 | -137 | -67 | 5.5 | 22 | 52 | 14 | 33 | 44 | 34 | 12 | -214 | 7.8 | 16 | -216 | -91 | -1.1 | 53 | 27 | 63 | 55 | 39 | 34 | 13 | -0.3 | 50 | 40 | 45 | -140 | 42 | 38 | 71 | 66 | 216 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.1 | 11 | 0.6 | 0.6 | 0.3 | 3.2 | 192 | 0.8 | 0.4 | 1.4 | 1.3 | 1.3 | 0.6 | 1.8 | 1.5 | 1.8 | 0.6 | 0.1 | 2.9 | 0.0 | -0.3 | 1.5 | 2.0 | 1.7 | -0.4 | – | 1.2 | – | 0.4 | – | 0.8 | – | 0.3 | – | 0.7 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | – | – | – | |
| 0.0 | -0.1 | 72 | 11 | 0.6 | 1.7 | 4.2 | 3.2 | 192 | 5.3 | 4.1 | 1.4 | 1.3 | 1.5 | 2.8 | 1.8 | 1.5 | 194 | 211 | -12 | -2.3 | 7.6 | -6.8 | -7.7 | -5.4 | -8.9 | -9.0 | -9.2 | -4.8 | -12 | 121 | -9.4 | -11 | -7.7 | -5.8 | 139 | -7.1 | -9.6 | -14 | 18 | -13 | |
| -2.0 | -3.3 | 57 | -24 | 2.2 | -13 | 25 | 35 | 36 | -66 | -20 | -0.7 | 24 | -9.8 | -0.1 | 25 | -1.0 | 245 | -47 | -34 | -29 | 117 | -153 | -70 | -2.8 | -22 | -27 | -1.5 | -16 | -19 | 78 | -55 | -1.1 | 0.9 | 73 | -51 | -21 | -24 | -19 | 21 | -43 | |
| -14 | -25 | -20 | -11 | -18 | -16 | 56 | 68 | -23 | -9.0 | -32 | -29 | -32 | -27 | -40 | -25 | -43 | 27 | -75 | -50 | -61 | 312 | -67 | -71 | -56 | -45 | -86 | -50 | -51 | -42 | -56 | -46 | -41 | -33 | 33 | -50 | -56 | -53 | -77 | -63 | -250 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.